← Open Payments lookup

CARL WHEELER: Open Payments

NPI 1134161425 · ANNAPOLIS, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$423 in 18 payments from 11 companies in 2025. Trend: 2023 $34 · 2024 $0 · 2025 $423

Food & beverage: $423
CompanyPaymentsAmount
Janssen Biotech, Inc.3$91
Madrigal Pharmaceuticals2$66
Phathom Pharmaceuticals, Inc.3$50
Takeda Pharmaceuticals U.S.A., Inc.2$40
Novo Nordisk Inc1$28
QOL Medical, LLC2$28
Regeneron Healthcare Solutions, Inc.1$26
Digestive Care, Inc.1$25
Salix Pharmaceuticals, a division of Bausch Health US, LLC1$24
PFIZER INC.1$23

Products named: TREMFYA, REZDIFFRA, VOQUEZNA, Wegovy, Sucraid, DUPIXENT, Pertzye, XIFAXAN.

Industry payments across MD — which companies pay providers there.